ImpediMed Limited (ASX: IPD)
Health Care · Health Care Equipment & Supplies · US
AU$0.01
+20.00% today · -87.2% 1Y
ImpediMed Limited (ASX: IPD) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $15.33M and employs 66 people.
Over the last twelve months the share price has lost 87.2%, trading between 0.00 and 0.05.
Tweenvest scores ImpediMed Limited across four factors: quality 34/100, value 50/100, growth 86/100. Its strongest factor is growth.
IPD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.33M
- Revenue (TTM)
- $10.11M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.07
- 52-week high
- AU$0.05
- 52-week low
- AU$0.00
- Avg volume (3M)
- —
- Shares outstanding
- 3.66B
- Employees
- 66
- Next earnings
- —
About ImpediMed Limited
Operating as a medical software technology provider, ImpediMed Limited is responsible for the development, production, and global sales of bioimpedance spectroscopy (BIS) instruments and accompanying software solutions, serving markets in Australia, North America, and internationally. Its product portfolio features SOZO, a non-invasive BIS device used for evaluating lymphedema and tracking fluid levels in heart failure patients. Additionally, it offers the SFB7, a single-channel, tetrapolar BIS instrument for analyzing body composition in healthy individuals, and ImpediVET, another single-channel, tetrapolar BIS device specifically designed for veterinary applications to measure fluid status and tissue composition. ImpediMed primarily sells its technology to hospitals and clinics. This Australian-headquartered firm, based in Pinkenba, was established in 1999.
- ISIN
- AU000000IPD8
- Founded
- 1999
- Listed since
- Oct 24, 2007
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Health & Life Co., Ltd.TPEX: 1781 | $16.16M | NT$10.90 | +9.11% |
| Laboratoires Euromedis Société anonymeENXTPA: ALEMG | $15.99M | €5.00 | -0.99% |
| IRIDEX CorporationNasdaqCM: IRIX | $15.63M | $0.94 | +5.78% |
| Avience Biomedicals LimitedNSEI: AVIENCE | $15.56M | Rs274.50 | -15.21% |
| Pulsenmore Ltd.TASE: PLSM | $15.32M | ₪5.82 | -15.45% |
| HeartSciences Inc.NasdaqCM: HSCS | $15.26M | $3.21 | +0.94% |
| Scandinavian Real Heart AB (Publ)OM: HEART | $15.08M | Skr17.85 | +0.56% |
| Etropal ADBUL: ETR | $14.89M | €2.62 | -1.50% |
Figures last refreshed Oct 11, 2026.